CAS 1001600-56-1

Fórmula: C70H96N10O8

InChI: InChI=1S/C70H96N10O8/c1-47(71-3)63(81)75-59(53-37-21-11-22-38-53)69(87)79-45-27-41-55(79)65(83)77-61(57(49-29-13-7-14-30-49)50-31-15-8-16-32-50)67(85)73-43-25-5-6-26-44-74-68(86)62(58(51-33-17-9-18-34-51)52-35-19-10-20-36-52)78-66(84)56-42-28-46-80(56)70(88)60(54-39-23-12-24-40-54)76-64(82)48(2)72-4/h7-10,13-20,29-36,47-48,53-62,71-72H,5-6,11-12,21-28,37-46H2,1-4H3,(H,73,85)(H,74,86)(H,75,81)(H,76,82)(H,77,83)(H,78,84)/t47-,48-,55-,56-,59-,60-,61-,62-/m0/s1

Clave InChI: DPXJXGNXKOVBJV-YLOPQIBLSA-N

SMILES: C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)NCCCCCCNC(=O)[C@H](C(C5=CC=CC=C5)C6=CC=CC=C6)NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)NC

(2S,2'S)-N,N'-((2S,2'S)-(Hexane-1,6-diylbis(azanediyl))bis(1-oxo-3,3-diphenylpropane-1,2-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide)

CAS: 1001600-56-1

Fórmula: C₇₀H₉₆N₁₀O₈

Pureza: 99%

Peso molecular: 1205.5734

Ref: IN-DA008TER

BV6

CAS: 1001600-56-1

BV6

Fórmula: C₇₀H₉₆N₁₀O₈

Pureza: ≥95%

Peso molecular: 1205.57

Ref: 54-BUP09225

BV6

CAS: 1001600-56-1

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

Fórmula: C₇₀H₉₆N₁₀O₈

Pureza: 97.46% - 99.82%

Forma y color: Solid

Peso molecular: 1205.57

Ref: TM-T6428

BV6

CAS: 1001600-56-1

(2S,2'S)-N,N'-((2S,2'S)-(Hexane-1,6-diylbis(azanediyl))bis(1-oxo-3,3-diphenylpropane-1,2-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide)

Fórmula: C₇₀H₉₆N₁₀O₈

Pureza: 99%

Peso molecular: 1205.57

Ref: IN-DG629814

BV-6

Producto controlado

CAS: 1001600-56-1

Fórmula: C₇₀H₉₆N₁₀O₈

Forma y color: Neat

Peso molecular: 1205.6

Ref: TR-B810530

BV6

CAS: 1001600-56-1

BV6 is a mouse tumor that has been shown to be clinically relevant in vivo. It induces necrotic cell death, which has been shown to be TNFR-related apoptosis-inducing and apoptosis protein-mediated. BV6 also induces mitochondrial membrane potential and chemoattractant protein release, both of which are involved in the pathogenesis of tumor cells. This compound induces fatty acid production, which may be a potential biomarker for primary sclerosing cholangitis and colorectal cancer. Monoclonal antibodies have been developed to treat this tumor, as well as other types of tumors.

Fórmula: C₇₀H₉₆N₁₀O₈

Pureza: Min. 95%

Peso molecular: 1,205.59 g/mol

Ref: 3D-BQB60056